Navigation Links
4th International Nanomedicine Conference

The Australian Centre for Nanomedicine (ACN) at UNSW is hosting the fourth International Nanomedicine Conference from 1 3 July in Sydney.

The conference will bring together world-leading experts to highlight research into new drugs, targeted drug delivery systems, diagnostics and imaging, and regenerative medicine.

The ACN is an interdisciplinary research centre comprising UNSW scientists, engineers and clinicians who are working together to develop new treatments that could deliver a mighty blow in the fight against currently incurable diseases, including a range of chemo-resistant cancers.

Nanomedicine involves the development of new treatment and detection strategies in medicine that arise from nanotechnology, such as the synthesis of nano-sized particles that have been engineered to perform a very specific function inside the body.

One nanometre is equivalent to one-billionth of a metre and is roughly 60,000 times thinner than a human hair. A single strand of DNA is just three nanometres wide.

At this sub-microscopic scale, materials sometimes exhibit curious physical, chemical and biological properties. These can be exploited to create particles that release drugs in a highly controlled way or to develop sensors that can provide early detection of disease.

Keynote speakers include:

  • Heather Maynard, Director of the Chemistry Biology Interface Training Program at UCLA
  • John Mattick, Director of the Garvan Institute of Medical Research in Sydney
  • Scott McNeil, Director of the Nanotechnology Characterization Lab in Maryland, US

Things to watch from the Australian Centre for Nanomedicine at UNSW:

Researchers have begun work on a new drug that will target chemo-resistant pancreatic cancer. The objective is to break down and halt the spread of the cancer cells, and to simultaneously "switch off" genes associated with its development. Professor Maria Kavallaris, Co-Director of the Centre, says there are certainly "future applications across a range of cancers".

  • Phoebe Phillips from UNSW Medicine will speak about this work

UNSW researchers have teamed up with Sydney-based biotech company Benitec Biopharma to develop a "gene silencing" technology that has been shown in preclinical models to dramatically improve the effectiveness of chemotherapy in lung cancer.

  • Michael Graham, Chief Scientist at Benitec Biopharma, will speak about this work and how the company's unique gene silencing approach can target other diseases such as hepatitis C.

Event Details:

What: 4th Annual International Nanomedicine Conference
Where: Intercontinental Hotel, 117 Macquarie Street, Sydney CBD
When: 1-3 July 2013
Register online and see the full list of speakers at:


Contact: Myles Gough
University of New South Wales

Related biology news :

1. PETA International Science Consortium disappointed in denial of Dow appeal
2. First international collaboration to showcase latest body of evidence of dairy health benefits
3. SPIE on global team proposing International Year of Light at United Nations
4. CLEO: 2013 -- the Premier International Laser and Electro-Optics Event in San Jose next week
5. New review sets international standards for best practice in fracture liaison services
6. BGI hosts its 2nd International Conference on Genomics in the Americas
7. Drive-Up Biometric System from SRI International Sarnoff Wins New Product Showcase Award at ISC West 2013
8. International conference will put agri-food supply chain under the microscope
9. International collaboration to investigate disappearing reptiles and amphibians
10. International conference to tackle climate-change threats to agriculture
11. International study: Excess dietary salt may drive the development of autoimmune diseases
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, announced today that it will report ... 2016 on Thursday, October 22, 2015, after the ... corresponding conference call for analysts and investors at ... management may discuss forward-looking information.    ...
(Date:10/7/2015)... October 7, 2015 NXTD ) ... on the growing mobile commerce market and creator of ... Washington , former long- term executive at American Express ... --> NXTD ) ("NXT-ID" or the "Company"), a ... market and creator of the Wocket® smart wallet announces ...
(Date:10/2/2015)... , Oct. 02 2015 ... of the "Enforcing the Law Using Biometrics" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Enforcing the Law Using Biometrics" ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... the United States , Canada ... 14% of all new cases of kidney cancer.   --> ... and Europe .  PRCC represents about 14% ... Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison ... ("AstraZeneca") have completed enrolment in a global Phase II study of ...
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
(Date:10/12/2015)... , October 12, 2015 cell ... 6.49 billion by 2022, according to a new report by ... attributed to rise in incidence of oncology diseases and other ... is expected to reach USD 6.49 billion by 2022, ... This growth in demand can be attributed to rise in ...
(Date:10/12/2015)... 2015  Patara Pharma, a clinical-stage biotechnology company ... and conditions, today announced the closing of a ... with the close of its sale of preferred ... Security Agreement with Silicon Valley Bank whereby the ... will use the funds from the financing to ...
Breaking Biology Technology: